Clin2
NCT06710158Possibly a fitRecruiting

SC-102 for advanced solid tumors

Advanced Solid Cancers

Part of Cancer clinical trials.

This trial tests a new drug called SC-102 in people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if SC-102 is safe and how well it works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
120 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 18 to 75 years old.
  • You have advanced solid tumors that have spread or come back, and you've tried all standard treatments.
  • You are healthy enough to be up and about (ECOG score 0 or 1).
  • You have not had other cancers in the last 3 years (some early-stage cancers are okay).
  • You have not had any cancer treatment or major surgery in the last 4 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05911464Recruiting· Phase 1
Study drug HS-10386 for advanced solid tumor cancers

This Phase 1 trial tests HS-10386 (an experimental treatment) in people with advanced solid tumors that can’t be cured with standard options. The goal is to find a safe dose and see how the cancer responds.

Shanghai, Shanghai Municipality
NCT06944444Recruiting· Phase 1
Testing a new drug for advanced tumors

This trial tests a new drug, SSS59, in people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and how it affects the body.

Shanghai, Shanghai Municipality
NCT06220838Recruiting· Phase 1
Study of SC-101 for advanced solid tumors

This trial tests a new drug called SC-101 in people with advanced solid tumors that have not responded to other treatments. It may be an option if your tumor shows a specific protein called Nectin-4, which the drug targets.

Beijing, Beijing Municipality
NCT06772415Recruiting· Phase 1
Study of GenSci122 for advanced solid tumors

This trial tests an experimental pill called GenSci122 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug is safe and can help shrink tumors.

Beijing, Beijing Municipality
NCT07681882Recruiting· Phase 1
Testing DS1025a in people with advanced solid tumors

This trial tests a new drug, DS1025a, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and how well it works.

Kashiwa
NCT07252414Recruiting· Phase 1
Study of GenSci143 for advanced solid tumors

This trial tests a new drug, GenSci143, for people with advanced solid tumors that have stopped responding to standard treatments. It may be an option if your cancer has spread or come back and you have no other standard options left.

Zhengzhou, Henan

Hear when a new Advanced Solid Cancers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.